Event at 2017 IBC Show raised more than $39,000 US for non-profits supporting increased diversity and inclusion; nine sponsors already signed on for 2018 run

LONDON -Friday 17 August 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- AWS Elemental, an Amazon Web Services (AWS) company, today announced that the fifth annual 4K 4Charity Fun Run at IBC Show will take place at 7:00 a.m. local time on Saturday, Sept. 15 at Amstelpark in Amsterdam. Registration is open at https://4k4charity.com/ibc.

Among the non-profits supported by the 4K 4Charity Fun Run at IBC Show is Amsterdam-based StichtingNewTechKids, which provides computer science education for girls, minorities, and economically challenged youth in the Netherlands. The organization supports a computer science teacher training program for primary school teachers with proceeds from 4K 4Charity. Also supported is Iridescent, a global education non-profit that empowers underrepresented young people to become innov ... Read more »

... Read more »

Multi-line global insurer to use cloud-native economic cyber risk modeling solution built to help insurers quantify cyber risk exposures

FOSTER CITY, Calif. -Friday 17 August 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Guidewire Software, Inc. (NYSE: GWRE), the provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced that Zurich Insurance Group (Zurich) has selected Guidewire Cyence™ Risk Analytics (Cyence) to leverage the cyber risk knowledge and insights the solution provides to help the company prospect, underwrite, and price risks. Zurich will roll out Cyence globally with an emphasis on enhanced analytics and intelligence for risk selection.

Unprecedented technological advances of the 21st century have shifted the nature of risk across the P&C insurance industry. Ever-evolving cyber risks present unique challenges including limited availability of traditional actuarial data needed to model t ... Read more »

Promising new platform can rapidly respond to emerging infectious diseases

SIOUX FALLS, S.D. -Friday 17 August 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases. The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United ... Read more »